Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus standard quadrivalent influenza vaccination in young infants
ACTRN12620000644965Phase 2Suspended
- Sponsor
- Kids Research Institute Australia
- Start
- Jul 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of quadrivalent influenza vaccine in influenza (2 arms), sponsored by Kids Research Institute Australia. Primary endpoints: Frequency of solicited local and systemic reactions, Severity of solicited local and systemic reactions and 1 more. Started Jul 2020; status: suspended.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on ACTRN12620000644965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000644965.